Drug search by name

Fluoxetine Delayed-Release Capsules and Renal dysfunction

Result of checking the interaction of drug Fluoxetine Delayed-Release Capsules and disease Renal dysfunction for safety when used together.

Check result:

Fluoxetine Delayed-Release Capsules <> Renal dysfunction

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Fluoxetine is primarily metabolized by the liver. All but one metabolites are inactive, and they are excreted by the kidney. The clearance of norfluoxetine, the active metabolite, is not dependent on renal function. Dosage adjustments are generally not deemed necessary in patients with impaired renal function, although the clinical significance of possible metabolite accumulation is unknown. Caution may be warranted when fluoxetine therapy is administered in patients with severe renal dysfunction.

References:

"Product Information. Prozac (fluoxetine)." Dista Products Company, Indianapolis, IN.
Aronoff GR, Bergstrom RF, Pottratz ST, Sloan RS, Wolen RL, Lemberger L "Fluoxetine kinetics and protein binding in normal and impaired renal function." Clin Pharmacol Ther 36 (1984): 138-44

Fluoxetine Delayed-Release Capsules

Generic Name: fluoxetine

Brand Name: Prozac, Prozac Weekly, PROzac Pulvules, Sarafem, Rapiflux, Selfemra

Synonyms: Fluoxetine, FLUoxetine

What is Fluoxetine Delayed-Release Capsules?